![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:AFF3-DMD (FusionGDB2 ID:HG3899TG1756) |
Fusion Gene Summary for AFF3-DMD |
![]() |
Fusion gene information | Fusion gene name: AFF3-DMD | Fusion gene ID: hg3899tg1756 | Hgene | Tgene | Gene symbol | AFF3 | DMD | Gene ID | 3899 | 1756 |
Gene name | AF4/FMR2 family member 3 | dystrophin | |
Synonyms | LAF4|MLLT2-like | BMD|CMD3B|DXS142|DXS164|DXS206|DXS230|DXS239|DXS268|DXS269|DXS270|DXS272|MRX85 | |
Cytomap | ('AFF3')('DMD') 2q11.2 | Xp21.2-p21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | AF4/FMR2 family member 3MLLT2-related proteinlymphoid nuclear protein 4lymphoid nuclear protein related to AF4protein LAF-4 | dystrophin | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | P51826 | P11532 | |
Ensembl transtripts involved in fusion gene | ENST00000317233, ENST00000356421, ENST00000409236, ENST00000409579, ENST00000483600, | ||
Fusion gene scores | * DoF score | 17 X 13 X 7=1547 | 35 X 39 X 12=16380 |
# samples | 17 | 41 | |
** MAII score | log2(17/1547*10)=-3.18586654531133 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(41/16380*10)=-5.32016763702292 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: AFF3 [Title/Abstract] AND DMD [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | AFF3(100223332)-DMD(31466150), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | DMD | GO:0043043 | peptide biosynthetic process | 16000376 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for AFF3-DMD |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for AFF3-DMD |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for AFF3-DMD |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:100223332/:31466150) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
AFF3 | DMD |
FUNCTION: Putative transcription activator that may function in lymphoid development and oncogenesis. Binds, in vitro, to double-stranded DNA. | FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. {ECO:0000250|UniProtKB:P11531, ECO:0000269|PubMed:16710609}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for AFF3-DMD |
![]() |
Top |
Fusion Gene PPI Analysis for AFF3-DMD |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AFF3-DMD |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | DMD | P11532 | DB15593 | Golodirsen | Inducer | Biotech | Approved |
Top |
Related Diseases for AFF3-DMD |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AFF3 | C0003873 | Rheumatoid Arthritis | 2 | CTD_human |
Hgene | AFF3 | C0013146 | Drug abuse | 1 | CTD_human |
Hgene | AFF3 | C0013170 | Drug habituation | 1 | CTD_human |
Hgene | AFF3 | C0013222 | Drug Use Disorders | 1 | CTD_human |
Hgene | AFF3 | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Hgene | AFF3 | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Hgene | AFF3 | C0038580 | Substance Dependence | 1 | CTD_human |
Hgene | AFF3 | C0038586 | Substance Use Disorders | 1 | CTD_human |
Hgene | AFF3 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Hgene | AFF3 | C0740858 | Substance abuse problem | 1 | CTD_human |
Hgene | AFF3 | C1510472 | Drug Dependence | 1 | CTD_human |
Hgene | AFF3 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Hgene | AFF3 | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Tgene | C0013264 | Muscular Dystrophy, Duchenne | 18 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0917713 | Becker Muscular Dystrophy | 13 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C3542021 | Duchenne and Becker Muscular Dystrophy | 11 | CTD_human | |
Tgene | C0026850 | Muscular Dystrophy | 4 | CTD_human | |
Tgene | C3668940 | Dmd-Associated Dilated Cardiomyopathy | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0033141 | Cardiomyopathies, Primary | 3 | CTD_human | |
Tgene | C0036529 | Myocardial Diseases, Secondary | 3 | CTD_human | |
Tgene | C0878544 | Cardiomyopathies | 3 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0006663 | Calcinosis | 1 | CTD_human | |
Tgene | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human | |
Tgene | C0018800 | Cardiomegaly | 1 | CTD_human | |
Tgene | C0023269 | leiomyosarcoma | 1 | CTD_human | |
Tgene | C0026851 | Muscular Dystrophy, Animal | 1 | CTD_human | |
Tgene | C0027540 | Necrosis | 1 | CTD_human | |
Tgene | C0027626 | Neoplasm Invasiveness | 1 | CTD_human | |
Tgene | C0027627 | Neoplasm Metastasis | 1 | CTD_human | |
Tgene | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human | |
Tgene | C0038220 | Status Epilepticus | 1 | CTD_human | |
Tgene | C0151786 | Muscle Weakness | 1 | CTD_human | |
Tgene | C0205815 | Leiomyosarcoma, Epithelioid | 1 | CTD_human | |
Tgene | C0205816 | Leiomyosarcoma, Myxoid | 1 | CTD_human | |
Tgene | C0206656 | Embryonal Rhabdomyosarcoma | 1 | CTD_human | |
Tgene | C0238198 | Gastrointestinal Stromal Tumors | 1 | CTD_human | |
Tgene | C0242973 | Ventricular Dysfunction | 1 | CTD_human | |
Tgene | C0263628 | Tumoral calcinosis | 1 | CTD_human | |
Tgene | C0270823 | Petit mal status | 1 | CTD_human | |
Tgene | C0311335 | Grand Mal Status Epilepticus | 1 | CTD_human | |
Tgene | C0340427 | Familial dilated cardiomyopathy | 1 | ORPHANET | |
Tgene | C0393734 | Complex Partial Status Epilepticus | 1 | CTD_human | |
Tgene | C0521174 | Microcalcification | 1 | CTD_human | |
Tgene | C0751522 | Status Epilepticus, Subclinical | 1 | CTD_human | |
Tgene | C0751523 | Non-Convulsive Status Epilepticus | 1 | CTD_human | |
Tgene | C0751524 | Simple Partial Status Epilepticus | 1 | CTD_human | |
Tgene | C1136382 | Sclerocystic Ovaries | 1 | CTD_human | |
Tgene | C1383860 | Cardiac Hypertrophy | 1 | CTD_human | |
Tgene | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human | |
Tgene | C2931498 | Mental Retardation, X-Linked 1 | 1 | ORPHANET | |
Tgene | C3179349 | Gastrointestinal Stromal Sarcoma | 1 | CTD_human |